MaxCyte, Inc. Share Price
MXCTMaxCyte, Inc. Stock Performance
Open $0.81 | Prev. Close $0.81 | Circuit Range N/A |
Day Range $0.78 - $0.85 | Year Range $0.75 - $4.67 | Volume 24,934 |
Average Traded $0.81 |
MaxCyte, Inc. Share Price Chart
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
MaxCyte, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Feb-26 | $0.79 | $0.87 | +6.34% |
03-Feb-26 | $0.86 | $0.82 | -5.53% |
02-Feb-26 | $0.90 | $0.87 | -5.03% |
30-Jan-26 | $0.98 | $0.91 | -6.83% |
29-Jan-26 | $0.99 | $0.98 | -3.82% |
28-Jan-26 | $1.07 | $1.02 | -3.77% |
27-Jan-26 | $1.13 | $1.06 | -5.36% |